• Open Account

Aspira Pathlab & Diagnostics Ltd

Small Cap | Healthcare
Last updated: 10-Jun-2026 ,

Aspira Pathlab & Diagnostics Ltd Live Price Chart

Performance

Low: ₹0 High: 0
Previous Close
High
Volume 5
52W Range ₹ - ₹
Open
Low
Market Cap ₹ 69 Cr
Open Your Demat Account
with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges

Aspira Pathlab & Diagnostics Ltd Technicals

Current Price
No value
EMASMA
20 Day ₹ 111.718
50 Day ₹ 90.857
100 Day ₹ 78.488
200 Day ₹ 70.479
20 Day ₹ 112.270
50 Day ₹ 80.752
100 Day ₹ 70.870
200 Day ₹ 67.488

Aspira Pathlab & Diagnostics Ltd Fundamentals

ROCE 2.834
P/E Ratio 2,460.000
P/B Ratio 10.350
Industry P/E 10.350
Debt to Equity 80.892
ROE 0.419
EPS 0.050
Dividend Yield 0.000
Book Value 11.885
Face Value 10.000

Aspira Pathlab & Diagnostics Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 22.3879 13.626 14.7778 19.6366 15.4092
Total Expenses 20.3153 16.2982 14.8665 15.1772 14.0282
Profit After Tax 2.0726 -2.6722 -0.0887 4.4594 1.381

Aspira Pathlab & Diagnostics Ltd Shareholding Pattern

Promoter Holdings 18.391 %
FIIs 0.000 %
DIIs 0.000 %
MutualFund 0.000 %
Retail 60.059 %
Others - 21.550 %

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with Pan-India presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results. During the year 2016, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of 'Ankur Pathology Laboratory'. Aspira is focused on establishing itself as a strong regional player before scaling up its operations. Although, it follow an asset light model, other costs are significantly high. Most of these cost is front ended and the payback period is high. It is therefore working on building the right systems and optimize the cost. It is adopting new technologies that improve customer experience. Some of these are use of Chatbot, improving websit ...

FAQs on Aspira Pathlab & Diagnostics Ltd

1. Can I buy Aspira Pathlab & Diagnostics Ltd from PL Capital?

Yes, you can invest in Aspira Pathlab & Diagnostics Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Aspira Pathlab & Diagnostics Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Aspira Pathlab & Diagnostics Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Aspira Pathlab & Diagnostics Ltd pay dividends?

Aspira Pathlab & Diagnostics Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Aspira Pathlab & Diagnostics Ltd ?

As of 10-Jun-2026 , the share price for Aspira Pathlab & Diagnostics Ltd. is ₹ on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Aspira Pathlab & Diagnostics Ltd ?

The 52-week high and low of Aspira Pathlab & Diagnostics Ltd share price is ₹ - ₹ as of 10-Jun-2026 , .
App QR Code

Download the PL Capital App

Open Demat Account
×